Director Michael Patrick Miller sold Puma Biotechnology Inc. ($PBYI) shares once on the open market in the last year for a total of $97,228. His most recent sale occurred on November 11, 2025. These transactions rank 9,631st among 11,678 insiders in our database, where the average sale totals $8.6 million over 6.4 trades. Miller reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2026 | RIGEL PHARMACEUTICALS INC | $RIGL | MILLER MICHAEL PATRICK | Not found | A | Stock Option (right to buy) | 12000 | $0.00 | 12,000.0000 | 18,840,000 | 9999.99% | 0.06% |
| Jan. 9, 2026 | BioXcel Therapeutics, Inc. | $BTAI | MILLER MICHAEL PATRICK | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| Nov. 11, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MILLER MICHAEL PATRICK | Director | S | Common Stock | 20000 | $4.86 | 54,000.0000 | 50,929,893 | 27.03% | 0.04% |
| June 11, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MILLER MICHAEL PATRICK | Director | A | Common Stock | 27000 | $0.00 | 74,000.0000 | 49,100,433 | 57.45% | 0.05% |
| Aug. 12, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MILLER MICHAEL PATRICK | Director | S | Common Stock | 23358 | $3.49 | 47,000.0000 | 47,550,852 | 33.20% | 0.05% |
| June 18, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MILLER MICHAEL PATRICK | Director | A | Common Stock | 27000 | $0.00 | 95,358.0000 | 47,550,852 | 39.50% | 0.06% |
| June 10, 2024 | BioXcel Therapeutics, Inc. | $BTAI | MILLER MICHAEL PATRICK | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 1,929,000 | 9999.99% | 0.88% |
| Nov. 7, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MILLER MICHAEL PATRICK | Director | S | Common Stock | 25000 | $2.83 | 43,358.0000 | 44,929,998 | 36.57% | 0.06% |
| June 26, 2023 | BioXcel Therapeutics, Inc. | $BTAI | MILLER MICHAEL PATRICK | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 28,616,000 | 9999.99% | 0.06% |
| June 13, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MILLER MICHAEL PATRICK | Director | S | Common Stock | 13500 | $3.45 | 41,358.0000 | 44,929,998 | 24.61% | 0.03% |
| June 13, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | MILLER MICHAEL PATRICK | Director | A | Common Stock | 27000 | $0.00 | 68,358.0000 | 44,929,998 | 65.28% | 0.06% |